Human FNDC1 (Fibronectin type III domain-containing protein 1) ELISA KIT (HUFI05230)

The Assay Genie FNDC1 ELISA kit provides researchers with a quantitative tool for measuring fibronectin type III domain-containing protein 1 in human-derived research specimens. FNDC1 has emerged as a protein of significant interest in oncology, with published studies linking its expression to gastric carcinoma, esophageal squamous cell carcinoma, and prostate cancer progression. The protein's multi-domain architecture, characterized by tandem fibronectin type III repeats, supports its involvement in extracellular matrix interactions, cytoskeletal remodeling, and cell migration pathways.

This quantitative immunoassay is configured in a 96 Assays kit format suitable for laboratory workflows studying fibronectin-containing signaling networks. Researchers investigating tumor microenvironment dynamics, cell adhesion mechanisms, or angiogenic processes can apply the platform to characterize FNDC1 abundance in human research cohorts. The kit supports investigation of FNDC1 as a candidate biomarker in translational studies, particularly where differential expression between healthy and diseased tissue groups is being mapped.

Beyond oncology applications, the kit serves studies of muscle biology and developmental processes, since FNDC1 isoforms are expressed in skeletal muscle and have been implicated in regeneration responses. Each kit contains reagents validated for use with standard microplate readers, enabling absorbance-based quantification. The 96 Assays configuration delivers throughput appropriate for cohort-scale screening while preserving sample efficiency, making the platform accessible for both targeted biomarker studies and broader exploratory proteomics investigations of human FNDC1 biology.